A 30-year-old woman presented with recurrent acne lesions and progressing male-pattern baldness. Furthermore, she reported amenorrhea, weight loss, mucosal xerosis and dyspareunia since discontinuation of hormonal contraception 6 months earlier in order to conceive. Acne tarda and androgenetic alopecia of female pattern were diagnosed. Hormonal and immunologic serological and ultrasound examinations revealed an autoimmune hypergonadotropic primary ovarian insufficiency (POI) with no ovarian cysts but ovarian fibrosis with marked reduced follicle pool. Immediate ovarian stimulation and in vitro fertilization led to pregnancy and the patient gave birth to a healthy child. Though presenting with clinical findings similar to menopause, 50% of patients with POI exhibit varying and unpredictable ovarian function, and only 5-10% are able to accomplish pregnancy. Genetic disorders affect the X chromosome. In 14-30% of cases POI has been associated with autoimmunity. POI may occur after discontinuation of hormonal contraception, like in our case.

1.
Jin M, Yu Y, Huang H: An update on primary ovarian insufficiency. Sci China Life Sci 2012;55:677-686.
2.
Falorni A, Brozzetti A, Aglietti MC, Esposito R, Minarelli V, Morelli S, Sbroma Tomaro E, Marzotti S: Progressive decline of residual follicle pool after clinical diagnosis of autoimmune ovarian insufficiency. Clin Endocrinol 2012;77:453-458.
3.
Makrantonaki E, Zouboulis CC: The skin as a mirror of the aging process in the human organism - state of the art and results of the aging research in the German National Genome Research Network 2 (NGFN-2). Exp Gerontol 2007;42:879-886.
4.
Makrantonaki E, Zouboulis CC: Androgens and ageing of the skin. Curr Opin Endocrinol Diabetes Obes 2009;16:240-245.
5.
Nelson LM: Primary ovarian insufficiency. N Engl J Med 2009;360:606-614.
6.
Saoji VA: Premature ovarian failure due to cyclophosphamide: a report of four cases in dermatology practice. Indian J Dermatol Venereol Leprol 2008;74:128-132.
7.
Sills ES, Harmon KE, Tucker MJ: First reported convergence of premature ovarian failure and cutis marmorata telangiectatica congenita. Fertil Steril 2002;78:1314-1316.
8.
Orfanos CE, Adler YD, Zouboulis CC: The SAHA syndrome. Horm Res 2000;54:251-258.
9.
Witchel SF, Recabarren SE, Gonzalez F, Diamanti-Kandarakis E, Cheang KI, Duleba AJ, Legro RS, Homburg R, Pasquali R, Lobo R, Zouboulis CC, Kelestimur F, Fruzzetti F, Futterweit W, Norman RJ, Abbott DH: Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine 2012;42:526-534.
10.
De Vos M, Devroey P, Fauser BCJM: Primary ovarian insufficiency. Lancet 2010;376:911-921.
11.
Baker VL: Primary ovarian insufficiency in the adolescent. Curr Opin Obstet Gynecol 2013;25:375-381.
12.
Zhong Q, Layman LC: Genetic considerations in the patient with Turner syndrome - 45,X with or without mosaicism. Fertil Steril 2012;98:775-779.
13.
Trolle C, Hjerrild B, Cleemann L, Mortensen KH, Gravholt CH: Sex hormone replacement in Turner syndrome. Endocrine 2012;41:200-219.
14.
Bakalov VK, Gutin L, Cheng CM, Zhou J, Sheth P, Shah K, Arepalli S, Vanderhoof V, Nelson LM, Bondy CA: Autoimmune disorders in women with Turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun 2012;38:315-321.
15.
Persani L, Rossetti R, Cacciatore C: Genes involved in human premature ovarian failure. J Mol Endocrinol 2010;45:257-279.
16.
Perry JR, Corre T, Esko T, Chasman DI, Fischer K, Franceschini N, He C, Kutalik Z, Mangino M, Rose LM, Vernon Smith A, Stolk L, Sulem P, Weedon MN, Zhuang WV, Arnold A, Ashworth A, Bergmann S, Buring JE, Burri A, Chen C, Cornelis MC, Couper DJ, Goodarzi MO, Gudnason V, Harris T, Hofman A, Jones M, Kraft P, Launer L, Laven JS, Li G, McKnight B, Masciullo C, Milani L, Orr N, Psaty BM; ReproGen Consortium, Ridker PM, Rivadeneira F, Sala C, Salumets A, Schoemaker M, Traglia M, Waeber G, Chanock SJ, Demerath EW, Garcia M, Hankinson SE, Hu FB, Hunter DJ, Lunetta KL, Metspalu A, Montgomery GW, Murabito JM, Newman AB, Ong KK, Spector TD, Stefansson K, Swerdlow AJ, Thorsteinsdottir U, Van Dam RM, Uitterlinden AG, Visser JA, Vollenweider P, Toniolo D, Murray A: A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet 2013;22:1465-1472.
17.
Sammaritano LR: Menopause in patients with autoimmune diseases. Autoimmun Rev 2012;11:A430-A436.
18.
Smith JA, Vitale S, Reed GF, Grieshaber SA, Goodman LA, Vanderhoof VH, Calis KA, Nelson LM: Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol 2004;122:151-156.
19.
Hoek A, Schoemaker J, Drexhage HA: Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997;18:107-134.
20.
Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S, Furmaniak J, Smith BR, Merino MJ, Nelson LM: Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril 2007;84:958-965.
21.
Cervera R, Balash JU: Bidirectional effects of autoimmunity and reproduction. Hum Reprod Update 2008;14:359-366.
22.
Berry GT: Galactosemia and amenorrhea in the adolescent. Ann N Y Acad Sci 2008;1135:112-117.
23.
Kulaksizoglu M, Ipekci SH, Kebapcilar L, Kebapcilar AG, Korkmaz H, Akyurek F, Baldane S, Gonen MS: Risk factors for diabetes mellitus in women with primary ovarian insufficiency. Biol Trace Elem Res 2013;154:313-320.
24.
Gonzalez L, Witchel SF: The patient with Turner syndrome: puberty and medical management concerns. Fertil Steril 2012;98:780-786.
25.
Dréno B, Layton A, Zouboulis CC, López-Estebaranz JL, Zalewska-Janowska A, Bagatin E, Zampeli VA, Yutskovskaya Y, Harper JC: Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol 2013;27:1063-1070.
26.
Zouboulis CC, Bornstein SR: Haut und Hormone: Aktuelles aus der Dermato-Endokrinologie. Dtsch Med Wochenschr 2013;138:1561-1563.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.